As of 2026-09-26, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is -0.06 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.35 CAD, the upside of BetterLife Pharma Inc is -116.57%.
Based on its market price of 0.35 CAD and our intrinsic valuation, BetterLife Pharma Inc (BETR.CN) is overvalued by 116.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.06 - -0.06 | -0.06 | -116.57% |
| DDM - Stable | (0.15) - (0.50) | (0.33) | -193.3% |
| DDM - Multi | (0.21) - (0.55) | (0.31) | -187.7% |
| Market Cap (mil) | 43.57 |
| Beta | 0.03 |
| Outstanding shares (mil) | 124.48 |
| Enterprise Value (mil) | 44.16 |
| Market risk premium | 5.10% |
| Cost of Equity | 8.85% |
| Cost of Debt | 5.00% |
| WACC | 8.77% |